Review





Similar Products

94
Santa Cruz Biotechnology dcp1a
Inhibition of tRNA charging activates the ISR without inducing RNP granules. ( A ) U-2 OS cells were treated with 0.2% DMSO carrier, 20 µM halofuginone (HF), 250 µM sodium arsenite (As), or 1.25 µM thapsigargin (Tg) for 1 h, and Western blotting for phosphorylated and total eIF2α was done. Total protein ( n = 3 independent replicates) and molecular weights (in kilodaltons) are shown. ( B ) Translation activity was measured using bioorthogonal noncanonical amino acid tagging in cells treated as in A . Methionine or azidohomoalanine (AHA) was added 10 min prior to collection. The ratio of nascent to total protein is shown from n = 3 independent replicates. ( C ) U-2 OS cells stably expressing GFP-G3BP1 (green) were treated as in A and fixed, and nuclei were stained with Hoechst (blue). The percentage of cells with SGs was quantified from n = 3 independent experiments; ≥305 cells were counted in each condition. Scale bars, 10 µm. ( D ) Cells were treated as in C , and immunofluorescence and fluorescence in situ hybridization were done to detect UBAP2L (magenta), PABPC1 (cyan), and poly(A) RNA with oligo(dT) probes (yellow) ( n = 2 independent experiments). ( E ) Cells were treated with 0.2% DMSO, 20 µM HF plus 0.2% DMSO, 250 µM arsenite, or 1.25 µM thapsigargin for 1 h, and the percentage of cells with SGs was quantified ( n = 3 independent experiments); ≥287 cells were counted per treatment. ( F ) Cells were treated, and immunofluorescence microscopy was done as in D to detect the P-body marker <t>DCP1A.</t> Quantification of the percentage of cells with P-bodies (PBs) from n = 3 independent experiments is shown; ≥364 cells were counted per treatment. ( G ) Cells were treated as in C to detect XRN1 (magenta) and EDC4 (yellow) by immunofluorescence microscopy ( n = 2 independent experiments). ( H ) U-2 OS cells were treated as in E , and immunofluorescence microscopy was done to detect DCP1A. The percentage of cells with PBs from n = 3 independent experiments is shown; ≥351 cells were counted per treatment across all replicates. Representative images are shown with the average ± SEM for each experiment, and green, gray, and pink points represent the average of each replicate. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (*) P < 0.05, (**) P < 0.01, (***) P < 0.005, (****) P < 0.001.
Dcp1a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dcp1a/Dcp1a+Antibody/pmc13041551-4-0-2
Average 94 stars, based on 1 article reviews
dcp1a - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc dcp1a
Inhibition of tRNA charging activates the ISR without inducing RNP granules. ( A ) U-2 OS cells were treated with 0.2% DMSO carrier, 20 µM halofuginone (HF), 250 µM sodium arsenite (As), or 1.25 µM thapsigargin (Tg) for 1 h, and Western blotting for phosphorylated and total eIF2α was done. Total protein ( n = 3 independent replicates) and molecular weights (in kilodaltons) are shown. ( B ) Translation activity was measured using bioorthogonal noncanonical amino acid tagging in cells treated as in A . Methionine or azidohomoalanine (AHA) was added 10 min prior to collection. The ratio of nascent to total protein is shown from n = 3 independent replicates. ( C ) U-2 OS cells stably expressing GFP-G3BP1 (green) were treated as in A and fixed, and nuclei were stained with Hoechst (blue). The percentage of cells with SGs was quantified from n = 3 independent experiments; ≥305 cells were counted in each condition. Scale bars, 10 µm. ( D ) Cells were treated as in C , and immunofluorescence and fluorescence in situ hybridization were done to detect UBAP2L (magenta), PABPC1 (cyan), and poly(A) RNA with oligo(dT) probes (yellow) ( n = 2 independent experiments). ( E ) Cells were treated with 0.2% DMSO, 20 µM HF plus 0.2% DMSO, 250 µM arsenite, or 1.25 µM thapsigargin for 1 h, and the percentage of cells with SGs was quantified ( n = 3 independent experiments); ≥287 cells were counted per treatment. ( F ) Cells were treated, and immunofluorescence microscopy was done as in D to detect the P-body marker <t>DCP1A.</t> Quantification of the percentage of cells with P-bodies (PBs) from n = 3 independent experiments is shown; ≥364 cells were counted per treatment. ( G ) Cells were treated as in C to detect XRN1 (magenta) and EDC4 (yellow) by immunofluorescence microscopy ( n = 2 independent experiments). ( H ) U-2 OS cells were treated as in E , and immunofluorescence microscopy was done to detect DCP1A. The percentage of cells with PBs from n = 3 independent experiments is shown; ≥351 cells were counted per treatment across all replicates. Representative images are shown with the average ± SEM for each experiment, and green, gray, and pink points represent the average of each replicate. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (*) P < 0.05, (**) P < 0.01, (***) P < 0.005, (****) P < 0.001.
Dcp1a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dcp1a/DCP1A+Rabbit+mAb/pm41654163-105-66-67
Average 94 stars, based on 1 article reviews
dcp1a - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology anti dcp1a
Inhibition of tRNA charging activates the ISR without inducing RNP granules. ( A ) U-2 OS cells were treated with 0.2% DMSO carrier, 20 µM halofuginone (HF), 250 µM sodium arsenite (As), or 1.25 µM thapsigargin (Tg) for 1 h, and Western blotting for phosphorylated and total eIF2α was done. Total protein ( n = 3 independent replicates) and molecular weights (in kilodaltons) are shown. ( B ) Translation activity was measured using bioorthogonal noncanonical amino acid tagging in cells treated as in A . Methionine or azidohomoalanine (AHA) was added 10 min prior to collection. The ratio of nascent to total protein is shown from n = 3 independent replicates. ( C ) U-2 OS cells stably expressing GFP-G3BP1 (green) were treated as in A and fixed, and nuclei were stained with Hoechst (blue). The percentage of cells with SGs was quantified from n = 3 independent experiments; ≥305 cells were counted in each condition. Scale bars, 10 µm. ( D ) Cells were treated as in C , and immunofluorescence and fluorescence in situ hybridization were done to detect UBAP2L (magenta), PABPC1 (cyan), and poly(A) RNA with oligo(dT) probes (yellow) ( n = 2 independent experiments). ( E ) Cells were treated with 0.2% DMSO, 20 µM HF plus 0.2% DMSO, 250 µM arsenite, or 1.25 µM thapsigargin for 1 h, and the percentage of cells with SGs was quantified ( n = 3 independent experiments); ≥287 cells were counted per treatment. ( F ) Cells were treated, and immunofluorescence microscopy was done as in D to detect the P-body marker <t>DCP1A.</t> Quantification of the percentage of cells with P-bodies (PBs) from n = 3 independent experiments is shown; ≥364 cells were counted per treatment. ( G ) Cells were treated as in C to detect XRN1 (magenta) and EDC4 (yellow) by immunofluorescence microscopy ( n = 2 independent experiments). ( H ) U-2 OS cells were treated as in E , and immunofluorescence microscopy was done to detect DCP1A. The percentage of cells with PBs from n = 3 independent experiments is shown; ≥351 cells were counted per treatment across all replicates. Representative images are shown with the average ± SEM for each experiment, and green, gray, and pink points represent the average of each replicate. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (*) P < 0.05, (**) P < 0.01, (***) P < 0.005, (****) P < 0.001.
Anti Dcp1a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dcp1a/Dcp1a+Antibody/bio_rxiv__64898__2026__01__19__700337-240-29-30
Average 94 stars, based on 1 article reviews
anti dcp1a - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology immunofluorescence dcp1a santa cruz biotechnology sc
Inhibition of tRNA charging activates the ISR without inducing RNP granules. ( A ) U-2 OS cells were treated with 0.2% DMSO carrier, 20 µM halofuginone (HF), 250 µM sodium arsenite (As), or 1.25 µM thapsigargin (Tg) for 1 h, and Western blotting for phosphorylated and total eIF2α was done. Total protein ( n = 3 independent replicates) and molecular weights (in kilodaltons) are shown. ( B ) Translation activity was measured using bioorthogonal noncanonical amino acid tagging in cells treated as in A . Methionine or azidohomoalanine (AHA) was added 10 min prior to collection. The ratio of nascent to total protein is shown from n = 3 independent replicates. ( C ) U-2 OS cells stably expressing GFP-G3BP1 (green) were treated as in A and fixed, and nuclei were stained with Hoechst (blue). The percentage of cells with SGs was quantified from n = 3 independent experiments; ≥305 cells were counted in each condition. Scale bars, 10 µm. ( D ) Cells were treated as in C , and immunofluorescence and fluorescence in situ hybridization were done to detect UBAP2L (magenta), PABPC1 (cyan), and poly(A) RNA with oligo(dT) probes (yellow) ( n = 2 independent experiments). ( E ) Cells were treated with 0.2% DMSO, 20 µM HF plus 0.2% DMSO, 250 µM arsenite, or 1.25 µM thapsigargin for 1 h, and the percentage of cells with SGs was quantified ( n = 3 independent experiments); ≥287 cells were counted per treatment. ( F ) Cells were treated, and immunofluorescence microscopy was done as in D to detect the P-body marker <t>DCP1A.</t> Quantification of the percentage of cells with P-bodies (PBs) from n = 3 independent experiments is shown; ≥364 cells were counted per treatment. ( G ) Cells were treated as in C to detect XRN1 (magenta) and EDC4 (yellow) by immunofluorescence microscopy ( n = 2 independent experiments). ( H ) U-2 OS cells were treated as in E , and immunofluorescence microscopy was done to detect DCP1A. The percentage of cells with PBs from n = 3 independent experiments is shown; ≥351 cells were counted per treatment across all replicates. Representative images are shown with the average ± SEM for each experiment, and green, gray, and pink points represent the average of each replicate. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (*) P < 0.05, (**) P < 0.01, (***) P < 0.005, (****) P < 0.001.
Immunofluorescence Dcp1a Santa Cruz Biotechnology Sc, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dcp1a/Dcp1a+Antibody/pm41535071-277-36-38
Average 94 stars, based on 1 article reviews
immunofluorescence dcp1a santa cruz biotechnology sc - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology α dcp1
LSm14A localizes to puncta upon oxidative stress (A) Microscopic images of immunostaining of G3BP1 in LSm14AGFP transfected HeLa cells treated with water (vehicle control) and 1 mM H 2 O 2 for 2 h. Endogenous G3BP1 was detected using α-G3BP1 antibody. (B) Quantification for LSm14AGFP and G3BP1 puncta per cell as in (A). (C) Percentage colocalization of LSm14AGFP puncta with G3BP1 upon H 2 O 2 treatment. (D) Microscopic images of immunostaining of <t>DCP1</t> in LSm14AGFP transfected HeLa treated with water and 1 mM H 2 O 2 for 2 h. Endogenous DCP1 was detected using <t>α-DCP1</t> antibody. (E) Quantification for LSm14AGFP and DCP1 puncta per cell as in (D). (F) Percentage colocalization of LSm14AGFP puncta with DCP1 upon H 2 O 2 treatment. Data plots represent mean ± SEM from n = 3, where ‘ n ’ represents number of independent experiments. Two tailed paired t - test was used to calculate the statistical significance ‘*’. (G) Cell viability assays in eGFP or LSm14AGFP transfected HeLa cells treated with 2 mM H 2 O 2 for 2 h. Data plots represent mean ± SEM from n = 5, where ‘ n ’ represents number of independent experiments. Two tailed paired student’s t - test was used to calculate the statistical significance ‘*’. Asterisks indicate levels of statistical significance: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****).
α Dcp1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dcp1a/Dcp1a+Antibody/pmc12795261-33-0-2
Average 94 stars, based on 1 article reviews
α dcp1 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
Proteintech anti dcp1a
LSm14A localizes to puncta upon oxidative stress (A) Microscopic images of immunostaining of G3BP1 in LSm14AGFP transfected HeLa cells treated with water (vehicle control) and 1 mM H 2 O 2 for 2 h. Endogenous G3BP1 was detected using α-G3BP1 antibody. (B) Quantification for LSm14AGFP and G3BP1 puncta per cell as in (A). (C) Percentage colocalization of LSm14AGFP puncta with G3BP1 upon H 2 O 2 treatment. (D) Microscopic images of immunostaining of <t>DCP1</t> in LSm14AGFP transfected HeLa treated with water and 1 mM H 2 O 2 for 2 h. Endogenous DCP1 was detected using <t>α-DCP1</t> antibody. (E) Quantification for LSm14AGFP and DCP1 puncta per cell as in (D). (F) Percentage colocalization of LSm14AGFP puncta with DCP1 upon H 2 O 2 treatment. Data plots represent mean ± SEM from n = 3, where ‘ n ’ represents number of independent experiments. Two tailed paired t - test was used to calculate the statistical significance ‘*’. (G) Cell viability assays in eGFP or LSm14AGFP transfected HeLa cells treated with 2 mM H 2 O 2 for 2 h. Data plots represent mean ± SEM from n = 5, where ‘ n ’ represents number of independent experiments. Two tailed paired student’s t - test was used to calculate the statistical significance ‘*’. Asterisks indicate levels of statistical significance: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****).
Anti Dcp1a, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dcp1a/DCP1A+Antibody/pmc12779947-282-118-119
Average 94 stars, based on 1 article reviews
anti dcp1a - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
Bethyl dcp1a
LSm14A localizes to puncta upon oxidative stress (A) Microscopic images of immunostaining of G3BP1 in LSm14AGFP transfected HeLa cells treated with water (vehicle control) and 1 mM H 2 O 2 for 2 h. Endogenous G3BP1 was detected using α-G3BP1 antibody. (B) Quantification for LSm14AGFP and G3BP1 puncta per cell as in (A). (C) Percentage colocalization of LSm14AGFP puncta with G3BP1 upon H 2 O 2 treatment. (D) Microscopic images of immunostaining of <t>DCP1</t> in LSm14AGFP transfected HeLa treated with water and 1 mM H 2 O 2 for 2 h. Endogenous DCP1 was detected using <t>α-DCP1</t> antibody. (E) Quantification for LSm14AGFP and DCP1 puncta per cell as in (D). (F) Percentage colocalization of LSm14AGFP puncta with DCP1 upon H 2 O 2 treatment. Data plots represent mean ± SEM from n = 3, where ‘ n ’ represents number of independent experiments. Two tailed paired t - test was used to calculate the statistical significance ‘*’. (G) Cell viability assays in eGFP or LSm14AGFP transfected HeLa cells treated with 2 mM H 2 O 2 for 2 h. Data plots represent mean ± SEM from n = 5, where ‘ n ’ represents number of independent experiments. Two tailed paired student’s t - test was used to calculate the statistical significance ‘*’. Asterisks indicate levels of statistical significance: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****).
Dcp1a, supplied by Bethyl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dcp1a/DCP1A+Antibody/pm41197820-80-67-72
Average 90 stars, based on 1 article reviews
dcp1a - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

94
Proteintech 1 ap rrid ab 2879092
LSm14A localizes to puncta upon oxidative stress (A) Microscopic images of immunostaining of G3BP1 in LSm14AGFP transfected HeLa cells treated with water (vehicle control) and 1 mM H 2 O 2 for 2 h. Endogenous G3BP1 was detected using α-G3BP1 antibody. (B) Quantification for LSm14AGFP and G3BP1 puncta per cell as in (A). (C) Percentage colocalization of LSm14AGFP puncta with G3BP1 upon H 2 O 2 treatment. (D) Microscopic images of immunostaining of <t>DCP1</t> in LSm14AGFP transfected HeLa treated with water and 1 mM H 2 O 2 for 2 h. Endogenous DCP1 was detected using <t>α-DCP1</t> antibody. (E) Quantification for LSm14AGFP and DCP1 puncta per cell as in (D). (F) Percentage colocalization of LSm14AGFP puncta with DCP1 upon H 2 O 2 treatment. Data plots represent mean ± SEM from n = 3, where ‘ n ’ represents number of independent experiments. Two tailed paired t - test was used to calculate the statistical significance ‘*’. (G) Cell viability assays in eGFP or LSm14AGFP transfected HeLa cells treated with 2 mM H 2 O 2 for 2 h. Data plots represent mean ± SEM from n = 5, where ‘ n ’ represents number of independent experiments. Two tailed paired student’s t - test was used to calculate the statistical significance ‘*’. Asterisks indicate levels of statistical significance: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****).
1 Ap Rrid Ab 2879092, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+dcp1a/DCP1A+Antibody/pmc12706091-34-6-4
Average 94 stars, based on 1 article reviews
1 ap rrid ab 2879092 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Inhibition of tRNA charging activates the ISR without inducing RNP granules. ( A ) U-2 OS cells were treated with 0.2% DMSO carrier, 20 µM halofuginone (HF), 250 µM sodium arsenite (As), or 1.25 µM thapsigargin (Tg) for 1 h, and Western blotting for phosphorylated and total eIF2α was done. Total protein ( n = 3 independent replicates) and molecular weights (in kilodaltons) are shown. ( B ) Translation activity was measured using bioorthogonal noncanonical amino acid tagging in cells treated as in A . Methionine or azidohomoalanine (AHA) was added 10 min prior to collection. The ratio of nascent to total protein is shown from n = 3 independent replicates. ( C ) U-2 OS cells stably expressing GFP-G3BP1 (green) were treated as in A and fixed, and nuclei were stained with Hoechst (blue). The percentage of cells with SGs was quantified from n = 3 independent experiments; ≥305 cells were counted in each condition. Scale bars, 10 µm. ( D ) Cells were treated as in C , and immunofluorescence and fluorescence in situ hybridization were done to detect UBAP2L (magenta), PABPC1 (cyan), and poly(A) RNA with oligo(dT) probes (yellow) ( n = 2 independent experiments). ( E ) Cells were treated with 0.2% DMSO, 20 µM HF plus 0.2% DMSO, 250 µM arsenite, or 1.25 µM thapsigargin for 1 h, and the percentage of cells with SGs was quantified ( n = 3 independent experiments); ≥287 cells were counted per treatment. ( F ) Cells were treated, and immunofluorescence microscopy was done as in D to detect the P-body marker DCP1A. Quantification of the percentage of cells with P-bodies (PBs) from n = 3 independent experiments is shown; ≥364 cells were counted per treatment. ( G ) Cells were treated as in C to detect XRN1 (magenta) and EDC4 (yellow) by immunofluorescence microscopy ( n = 2 independent experiments). ( H ) U-2 OS cells were treated as in E , and immunofluorescence microscopy was done to detect DCP1A. The percentage of cells with PBs from n = 3 independent experiments is shown; ≥351 cells were counted per treatment across all replicates. Representative images are shown with the average ± SEM for each experiment, and green, gray, and pink points represent the average of each replicate. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (*) P < 0.05, (**) P < 0.01, (***) P < 0.005, (****) P < 0.001.

Journal: Genes & Development

Article Title: tRNA synthetase activity is required for stress granule and P-body assembly

doi: 10.1101/gad.353535.125

Figure Lengend Snippet: Inhibition of tRNA charging activates the ISR without inducing RNP granules. ( A ) U-2 OS cells were treated with 0.2% DMSO carrier, 20 µM halofuginone (HF), 250 µM sodium arsenite (As), or 1.25 µM thapsigargin (Tg) for 1 h, and Western blotting for phosphorylated and total eIF2α was done. Total protein ( n = 3 independent replicates) and molecular weights (in kilodaltons) are shown. ( B ) Translation activity was measured using bioorthogonal noncanonical amino acid tagging in cells treated as in A . Methionine or azidohomoalanine (AHA) was added 10 min prior to collection. The ratio of nascent to total protein is shown from n = 3 independent replicates. ( C ) U-2 OS cells stably expressing GFP-G3BP1 (green) were treated as in A and fixed, and nuclei were stained with Hoechst (blue). The percentage of cells with SGs was quantified from n = 3 independent experiments; ≥305 cells were counted in each condition. Scale bars, 10 µm. ( D ) Cells were treated as in C , and immunofluorescence and fluorescence in situ hybridization were done to detect UBAP2L (magenta), PABPC1 (cyan), and poly(A) RNA with oligo(dT) probes (yellow) ( n = 2 independent experiments). ( E ) Cells were treated with 0.2% DMSO, 20 µM HF plus 0.2% DMSO, 250 µM arsenite, or 1.25 µM thapsigargin for 1 h, and the percentage of cells with SGs was quantified ( n = 3 independent experiments); ≥287 cells were counted per treatment. ( F ) Cells were treated, and immunofluorescence microscopy was done as in D to detect the P-body marker DCP1A. Quantification of the percentage of cells with P-bodies (PBs) from n = 3 independent experiments is shown; ≥364 cells were counted per treatment. ( G ) Cells were treated as in C to detect XRN1 (magenta) and EDC4 (yellow) by immunofluorescence microscopy ( n = 2 independent experiments). ( H ) U-2 OS cells were treated as in E , and immunofluorescence microscopy was done to detect DCP1A. The percentage of cells with PBs from n = 3 independent experiments is shown; ≥351 cells were counted per treatment across all replicates. Representative images are shown with the average ± SEM for each experiment, and green, gray, and pink points represent the average of each replicate. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (*) P < 0.05, (**) P < 0.01, (***) P < 0.005, (****) P < 0.001.

Article Snippet: DCP1A , Santa Cruz Biotechnology , SC-100706 , 1:100 (immunofluorescence).

Techniques: Inhibition, Western Blot, Activity Assay, Stable Transfection, Expressing, Staining, Immunofluorescence, Fluorescence, In Situ Hybridization, Microscopy, Marker

Ribosome release rescues stress-induced RNP granule assembly upon tRNA synthetase inhibition. ( A ) U-2 OS cells stably expressing GFP-G3BP1 were treated with 180 µM emetine (eme) or 0.2% DMSO with 250 µM sodium arsenite (As) for 1 h. Immunofluorescence microscopy was performed for P-body (PB) marker DCP1A, and the SG marker GFP-G3BP1 was imaged. ( Right ) The percentage of cells with SGs or PBs was quantified from n = 3 independent experiments; ≥349 cells were counted per treatment across all replicates. ( B ) Cells were treated with 0.2% DMSO, 20 µM HF, 250 µM As, or 1.25 µM thapsigargin (Tg) with or without 10 µg/mL puromycin for 1 h, followed by imaging and quantification of SGs. The percentage of cells with SGs was quantified from n = 3 independent experiments ( bottom ), and representative images are shown ( top ); ≥350 cells were counted per treatment across all replicates. ( C ) Cells were treated with 20 µM HF in the presence or absence of 250 µM As, 1.25 µM Tg, or 10 µg/mL puromycin for 1 h. The percentage of cells with SGs was quantified from n = 3 independent experiments; ≥290 cells were counted per treatment across all replicates. ( D ) Cells were treated as in B , and IF for DCP1A was performed. The percentage of cells with P-bodies (PBs) was quantified from n = 3 independent experiments ( bottom ), and representative images are shown ( top ); ≥355 cells were counted per treatment across all replicates. ( E ) Cells were treated as in C , and IF was performed to detect DCP1A. The percentage of cells with PBs was quantified from n = 3 independent experiments ( bottom ), and representative images are shown ( top ); ≥339 cells were counted per treatment across all replicates. Quantification is reported as average ± SEM, with green, pink, or gray dots indicating the average of each replicate. Scale bars, 10 µm. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (*) P < 0.05, (***) P < 0.005, (****) P < 0.001.

Journal: Genes & Development

Article Title: tRNA synthetase activity is required for stress granule and P-body assembly

doi: 10.1101/gad.353535.125

Figure Lengend Snippet: Ribosome release rescues stress-induced RNP granule assembly upon tRNA synthetase inhibition. ( A ) U-2 OS cells stably expressing GFP-G3BP1 were treated with 180 µM emetine (eme) or 0.2% DMSO with 250 µM sodium arsenite (As) for 1 h. Immunofluorescence microscopy was performed for P-body (PB) marker DCP1A, and the SG marker GFP-G3BP1 was imaged. ( Right ) The percentage of cells with SGs or PBs was quantified from n = 3 independent experiments; ≥349 cells were counted per treatment across all replicates. ( B ) Cells were treated with 0.2% DMSO, 20 µM HF, 250 µM As, or 1.25 µM thapsigargin (Tg) with or without 10 µg/mL puromycin for 1 h, followed by imaging and quantification of SGs. The percentage of cells with SGs was quantified from n = 3 independent experiments ( bottom ), and representative images are shown ( top ); ≥350 cells were counted per treatment across all replicates. ( C ) Cells were treated with 20 µM HF in the presence or absence of 250 µM As, 1.25 µM Tg, or 10 µg/mL puromycin for 1 h. The percentage of cells with SGs was quantified from n = 3 independent experiments; ≥290 cells were counted per treatment across all replicates. ( D ) Cells were treated as in B , and IF for DCP1A was performed. The percentage of cells with P-bodies (PBs) was quantified from n = 3 independent experiments ( bottom ), and representative images are shown ( top ); ≥355 cells were counted per treatment across all replicates. ( E ) Cells were treated as in C , and IF was performed to detect DCP1A. The percentage of cells with PBs was quantified from n = 3 independent experiments ( bottom ), and representative images are shown ( top ); ≥339 cells were counted per treatment across all replicates. Quantification is reported as average ± SEM, with green, pink, or gray dots indicating the average of each replicate. Scale bars, 10 µm. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test. (*) P < 0.05, (***) P < 0.005, (****) P < 0.001.

Article Snippet: DCP1A , Santa Cruz Biotechnology , SC-100706 , 1:100 (immunofluorescence).

Techniques: Inhibition, Stable Transfection, Expressing, Immunofluorescence, Microscopy, Marker, Imaging

Amino acid deprivation activates the integrated stress response without inducing stress granules. ( A ) U-2 OS cells were placed in media without arginine (−Arg) for 1, 4, or 16 h or in the same media with arginine added back (+Arg) for 4 h, and a representative Western blot for total and P-eIF2α with total protein is shown. ( B ) As in A , with glutamine (Gln)-free media or with glutamine added back (+Gln). ( C ) U-2 OS cells stably expressing GFP-G3BP1 (green) were treated as in A , followed by immunofluorescence for P-body (PB) marker DCP1A (magenta), and nuclei were stained with Hoechst (blue). The percentages of cells with stress granules (SGs) and PBs were quantified from n = 3 independent experiments; ≥410 cells were counted for each condition. ( D ) As in C but with glutamine deprivation; ≥312 cells were counted for each condition. ( E ) Cells were treated with DMSO or 40 nM thapsigargin (Tg) for 1 h or starved of arginine or glutamine for 4 h followed by Western blotting for total or P-eIF2α, with total protein shown below . ( F ) GFP-G3BP1-expressing U-2 OS cells were treated with DMSO control or 40 nM Tg for 1 h, and immunofluorescence was done for DCP1A. The average percentage of cells with SGs or PBs is shown at the right ; ≥440 cells were counted per treatment. Scale bars, 10 µm. Molecular weights (in kilodaltons) are shown on each blot. Images are shown for each experiment ( n = 3 independent replicates), with quantifications reported as average ± SEM and with green, gray, and pink points representing the value for each replicate. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test for all but F , where a t -test was used. (*) P < 0.05, (**) P < 0.01, (****) P < 0.001.

Journal: Genes & Development

Article Title: tRNA synthetase activity is required for stress granule and P-body assembly

doi: 10.1101/gad.353535.125

Figure Lengend Snippet: Amino acid deprivation activates the integrated stress response without inducing stress granules. ( A ) U-2 OS cells were placed in media without arginine (−Arg) for 1, 4, or 16 h or in the same media with arginine added back (+Arg) for 4 h, and a representative Western blot for total and P-eIF2α with total protein is shown. ( B ) As in A , with glutamine (Gln)-free media or with glutamine added back (+Gln). ( C ) U-2 OS cells stably expressing GFP-G3BP1 (green) were treated as in A , followed by immunofluorescence for P-body (PB) marker DCP1A (magenta), and nuclei were stained with Hoechst (blue). The percentages of cells with stress granules (SGs) and PBs were quantified from n = 3 independent experiments; ≥410 cells were counted for each condition. ( D ) As in C but with glutamine deprivation; ≥312 cells were counted for each condition. ( E ) Cells were treated with DMSO or 40 nM thapsigargin (Tg) for 1 h or starved of arginine or glutamine for 4 h followed by Western blotting for total or P-eIF2α, with total protein shown below . ( F ) GFP-G3BP1-expressing U-2 OS cells were treated with DMSO control or 40 nM Tg for 1 h, and immunofluorescence was done for DCP1A. The average percentage of cells with SGs or PBs is shown at the right ; ≥440 cells were counted per treatment. Scale bars, 10 µm. Molecular weights (in kilodaltons) are shown on each blot. Images are shown for each experiment ( n = 3 independent replicates), with quantifications reported as average ± SEM and with green, gray, and pink points representing the value for each replicate. Statistical significance was assessed with an ordinary one-way ANOVA followed by Tukey's multiple comparisons test for all but F , where a t -test was used. (*) P < 0.05, (**) P < 0.01, (****) P < 0.001.

Article Snippet: DCP1A , Santa Cruz Biotechnology , SC-100706 , 1:100 (immunofluorescence).

Techniques: Western Blot, Stable Transfection, Expressing, Immunofluorescence, Marker, Staining, Control

LSm14A localizes to puncta upon oxidative stress (A) Microscopic images of immunostaining of G3BP1 in LSm14AGFP transfected HeLa cells treated with water (vehicle control) and 1 mM H 2 O 2 for 2 h. Endogenous G3BP1 was detected using α-G3BP1 antibody. (B) Quantification for LSm14AGFP and G3BP1 puncta per cell as in (A). (C) Percentage colocalization of LSm14AGFP puncta with G3BP1 upon H 2 O 2 treatment. (D) Microscopic images of immunostaining of DCP1 in LSm14AGFP transfected HeLa treated with water and 1 mM H 2 O 2 for 2 h. Endogenous DCP1 was detected using α-DCP1 antibody. (E) Quantification for LSm14AGFP and DCP1 puncta per cell as in (D). (F) Percentage colocalization of LSm14AGFP puncta with DCP1 upon H 2 O 2 treatment. Data plots represent mean ± SEM from n = 3, where ‘ n ’ represents number of independent experiments. Two tailed paired t - test was used to calculate the statistical significance ‘*’. (G) Cell viability assays in eGFP or LSm14AGFP transfected HeLa cells treated with 2 mM H 2 O 2 for 2 h. Data plots represent mean ± SEM from n = 5, where ‘ n ’ represents number of independent experiments. Two tailed paired student’s t - test was used to calculate the statistical significance ‘*’. Asterisks indicate levels of statistical significance: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****).

Journal: RNA Biology

Article Title: RGG-motif protein Scd6 affects oxidative stress response by regulating cytosolic caTalase T1 (Ctt1)

doi: 10.1080/15476286.2026.2613892

Figure Lengend Snippet: LSm14A localizes to puncta upon oxidative stress (A) Microscopic images of immunostaining of G3BP1 in LSm14AGFP transfected HeLa cells treated with water (vehicle control) and 1 mM H 2 O 2 for 2 h. Endogenous G3BP1 was detected using α-G3BP1 antibody. (B) Quantification for LSm14AGFP and G3BP1 puncta per cell as in (A). (C) Percentage colocalization of LSm14AGFP puncta with G3BP1 upon H 2 O 2 treatment. (D) Microscopic images of immunostaining of DCP1 in LSm14AGFP transfected HeLa treated with water and 1 mM H 2 O 2 for 2 h. Endogenous DCP1 was detected using α-DCP1 antibody. (E) Quantification for LSm14AGFP and DCP1 puncta per cell as in (D). (F) Percentage colocalization of LSm14AGFP puncta with DCP1 upon H 2 O 2 treatment. Data plots represent mean ± SEM from n = 3, where ‘ n ’ represents number of independent experiments. Two tailed paired t - test was used to calculate the statistical significance ‘*’. (G) Cell viability assays in eGFP or LSm14AGFP transfected HeLa cells treated with 2 mM H 2 O 2 for 2 h. Data plots represent mean ± SEM from n = 5, where ‘ n ’ represents number of independent experiments. Two tailed paired student’s t - test was used to calculate the statistical significance ‘*’. Asterisks indicate levels of statistical significance: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****).

Article Snippet: α-DCP1 , Santa Cruz Biotechnology, sc-100706.

Techniques: Immunostaining, Transfection, Control, Two Tailed Test